Online Clinical and Drug Information Resource Portal for Pharmacists & Doctors
  Home  |  ADRs+SEs  |  Drug Interactions  |  Clinical Pharmacokinetics  |  Renal  |  Drugs in Pregnancy  |
Palliative Care  |  Crushing Tablets  |  Lab Tests  |  Cardiovascular  |  Endocrinology  |  Urology  |  More >>

Download PDF format Download PDF format 

Potency of Topical Corticosteroids (UK Classification)

 

Class Potency Generic Name and Strength Brand Name and Formulation
Class I Very Potent Clobetasol Propionate 0.05% Dermovate Cream / Ointment / Scalp Application
Diflucortolone Valerate 0.3% Nerisone Forte Oily Cream / Ointment
Class II Potent Beclometasone Dipropionate 0.025% Generic Beclometasone Dipropionate Cream / Ointment
Betamethasone Valerate 0.1% Betnovate Cream / Ointment / Lotion / Scalp Application
Betamethasone Dipropionate 0.05% Diprosone Cream / Ointment / Lotion
Diflucortolone Valerate 0.1% Nerisone Cream / Oily Cream / Ointment
Fluocinolone Acetonide 0.025% Synalar Cream / Ointment / Gel
Fluocinonide 0.05% Metosyn FAPG Cream / Ointment
Fluticasone Propionate 0.05% Cutivate Cream
Fluticasone Propionate 0.005% Cutivate Ointment
Hydrocortisone Butyrate 0.1% Locoid Cream / Ointment / Scalp Lotion
Locoid Crelo Emulsion
Mometasone Furoate 0.1% Elocon Cream / Ointment / Scalp Lotion
Triamcinolone Acetonide 0.1% Aureocort Ointment *
Class III Moderate Alclometasone Dipropionate 0.05% Modrasone Cream
Betamethasone Valerate 0.025% Betnovate-RD Cream / Ointment
Clobetasone Butyrate 0.05% Eumovate Cream / Ointment
Fludroxycortide 0.0125% Haelan Cream / Ointment
Fluocinolone Acetonide 0.00625% Synalar 1 in 4 Dilution Cream / Ointment
Fluocortolone 0.25% Ultralanum Plain Cream / Ointment
Class IV Mild Hydrocortisone 0.1-2.5% Generic Hydrocortisone Cream / Ointment
Dioderm Cream
Fluocinolone Acetonide 0.0025% Synalar 1 in 10 Dilution Cream

* Compound preparation (also contains chlortetracycline hydrochloride 3%)

 

Notes

List of brand names and formulation is not exhaustive.

Generic and brand name data from:

1. British National Formulary (BNF) 69. 69th edition. London: British Medical Association and Royal Pharmaceutical Society of Great Britain, March 2015.

2. Summaries of Product Characteristics. Available at http://www.medicines.org.uk [Accessed on 29/07/15].

 

 

 

Prepared: 29th July 2015

 

Site Map